Evidence map›Paper›PMID 28383827›Full record

ReviewThe FEBS journal2017

ADP-ribosylation: new facets of an ancient modification.

Luca Palazzo, Andreja Mikoč, Ivan Ahel

Open access · bronzeAbstract readReview
In one paragraph

Review in The FEBS journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 144 citations in OpenAlex.

  1. Article
  2. Article
  3. NMR study of human macroPARPs domains:Biomolecular NMR assignments · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Poly-ADP-ribosylation dynamics, signaling, and analysis.Environmental and molecular mutagenesis · 2024
    Review
  13. Review
  14. Article
  15. Decoding Ubiquitin Modifications by Mass Spectrometry.Advances in experimental medicine and biology · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Luca PalazzoSir William Dunn School of Pathology, University of Oxford, UK.ORCID 0000-0002-5556-5549
Andreja MikočDivision of Molecular Biology, Ruđer Bošković Institute, Zagreb, Croatia.
Ivan AhelSir William Dunn School of Pathology, University of Oxford, UK.
University of Oxford · GBRuđer Bošković Institute · HR

Funding

Cancer Research UK 22284Cancer Research UK C35050/A22284European Research Council 281739Wellcome Trust 101794
6 · The paper itself

Abstract

Rapid response to environmental changes is achieved by uni- and multicellular organisms through a series of molecular events, often involving modification of macromolecules, including proteins, nucleic acids and lipids. Amongst these, ADP-ribosylation is of emerging interest because of its ability to modify different macromolecules in the cells, and its association with many key biological processes, such as DNA-damage repair, DNA replication, transcription, cell division, signal transduction, stress and infection responses, microbial pathogenicity and aging. In this review, we provide an update on novel pathways and mechanisms regulated by ADP-ribosylation in organisms coming from all kingdoms of life.

Indexed as

DNA RepairProtein Processing, Post-TranslationalADP Ribose TransferasesAgingAnimalsArchaeaBacteriaBiological EvolutionDNA DamageDNA ReplicationGene ExpressionHumansIsoenzymesNudix HydrolasesPhosphoric Diester HydrolasesPoly Adenosine Diphosphate RiboseADP Ribose Transferasesectonucleotide pyrophosphatase phosphodiesterase 1IsoenzymesNudix HydrolasesPhosphoric Diester HydrolasesPoly Adenosine Diphosphate RibosePyrophosphatasesADP-ribosylationcellular pathwaysmetabolism of ADP-ribosylationpoly(ADP-ribose) polymerasepost-translational modification

Identifiers

PMID28383827
PMCPMC7163968
OpenAlexW2604136844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.